0001104659-20-037930.txt : 20200324 0001104659-20-037930.hdr.sgml : 20200324 20200324213149 ACCESSION NUMBER: 0001104659-20-037930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200320 FILED AS OF DATE: 20200324 DATE AS OF CHANGE: 20200324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MICEK JOHN CENTRAL INDEX KEY: 0001243187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 20739839 MAIL ADDRESS: STREET 1: 300 HAMILTON AVENUE, 4TH FLOOR CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-896-5081 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 4 1 a4.xml 4 X0306 4 2020-03-20 0 0001585608 Jaguar Health, Inc. JAGX 0001243187 MICEK JOHN C/O JAGUAR HEALTH INC. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 1 0 0 0 Stock Option (right to buy) 0.45 2020-03-20 4 A 0 26533 0 A 2030-03-20 Common Stock 26533 26533 D Granted pursuant to the issuer's 2014 Stock Incentive Plan. The option grant was approved by the issuer's board of directors on March 20, 2020. The option will vest ratably on a monthly basis over 36 months from the grant date, so long as the director remains employed by the issuer. /s/ Lisa A. Conte, Attorney-in-Fact 2020-03-24